Peritoneal migration of an epicardial pacemaker.

therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Europace 2013;15:1070–118. 20. Urena M, Webb JG, Eltchaninoff H, Munoz-Garcia AJ, Bouleti C, Tamburino C et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol 2015;65:437–48. 21. Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 2015;101:1665–71. 22. Mouillet G, Lellouche N, Yamamoto M, Oguri A, Dubois-Rande J-L, Van Belle E et al. Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(w) devices: results from the FRANCE 2 registry. Catheter Cardiovasc Interv 2015;166:158–66. 23. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 2012;60:493–501. 24. Houthuizen P, Van Der Boon RMA, Urena M, Van Mieghem N. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 2014;9:1142–50. Severe conduction defects requiring permanent pacemaker implantation 1021